• 更多栏目

    刘宇博

    • 教授     博士生导师   硕士生导师
    • 性别:男
    • 毕业院校:大连理工大学
    • 学位:博士
    • 所在单位:化工海洋与生命学院
    • 学科:生物化学与分子生物学. 生物化工. 化学生物学
    • 办公地点:大连理工大学 盘锦校区 生命与医药学院 F03-314
    • 联系方式:liuyubo@dlut.edu.cn
    • 电子邮箱:liuyubo@dlut.edu.cn

    访问量:

    开通时间:..

    最后更新时间:..

    Reduced expression of ppGalNAc-T4 promotes proliferation of human breast cancer cells

    点击次数:

    论文类型:期刊论文

    发表时间:2021-03-10

    发表刊物:CELL BIOLOGY INTERNATIONAL

    卷号:45

    期号:2

    页面范围:320-333

    ISSN号:1065-6995

    关键字:breast cancer cell; cell cycle; cell growth; Notch signaling pathway; ppGalNAc‐ T4; RNA‐ sequencing

    摘要:Breast cancer, one of the most frequently diagnosed and aggressive malignancies, is the major cause of cancer-related death greatly threatening women health. Polypeptide N-acetylgalactosaminyltransferase 4 (ppGalNAc-T4), responsible for the initial step of mucin-type O-glycosylation, has been reported to be implicated in diverse types of human tumors. However, the biological role of ppGalNAc-T4 in breast cancer is still undetermined. In this study, we investigate the effects and mechanism of ppGalNAc-T4 to breast cancer cell proliferation. From analysis of high throughput RNA sequencing datasets of Gene Expression Omnibus and ArrayExpress, a positive correlation between ppGalNAc-T4 and the recurrence-free survival was observed in multigroup of human breast cancer datasets. Moreover, transcriptomes analysis using RNA-sequencing in MCF7 cells revealed that cell cycle-related genes induced the effects of ppGalNAc-T4 on breast cancer cell proliferation. Additionally, investigations showed that ppGalNAc-T4 impaired cell proliferation in MCF-7 and MDA-MB-231 breast cells. Furthermore, our results suggested that the ppGalNAc-T4 knockout activated Notch signaling pathway and enhanced cell proliferation. Collectively, our data indicated that ppGalNAc-T4 affected the proliferation of human breast cancer cells, which appears to be a novel target for understanding the underlying molecular mechanism of breast cancer.